Rice Hall James & Associates’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-212,864
| Closed | -$2.15M | – | 264 |
|
|
2022
Q4 | $2.15M | Sell |
212,864
-6,282
| -3% | -$63.4K | 0.12% | 182 |
|
|
2022
Q3 | $4.91M | Sell |
219,146
-53,887
| -20% | -$1.21M | 0.28% | 86 |
|
|
2022
Q2 | $6.77M | Buy |
273,033
+27,117
| +11% | +$672K | 0.33% | 71 |
|
|
2022
Q1 | $9.53M | Sell |
245,916
-4,296
| -2% | -$167K | 0.38% | 69 |
|
|
2021
Q4 | $14.6M | Sell |
250,212
-10,544
| -4% | -$617K | 0.52% | 51 |
|
|
2021
Q3 | $15.5M | Sell |
260,756
-74,671
| -22% | -$4.43M | 0.57% | 54 |
|
|
2021
Q2 | $29.1M | Sell |
335,427
-48,935
| -13% | -$4.25M | 1.04% | 29 |
|
|
2021
Q1 | $31.7M | Sell |
384,362
-2,965
| -0.8% | -$244K | 1.03% | 32 |
|
|
2020
Q4 | $35.2M | Buy |
387,327
+60,483
| +19% | +$5.5M | 1.24% | 24 |
|
|
2020
Q3 | $13.1M | Buy |
+326,844
| New | +$13.1M | 0.53% | 53 |
|